Renowned psychiatrist, author and social activist Dr Anand Nadkarni died at 67 after a prolonged illness on Friday. Best ...

Peru is expanding access to surgery and care for patients with cleft conditions in remote areas through intensive ...

Invivyd (NASDAQ:IVVD) said its first quarter of 2026 was marked by continued progress in its pivotal COVID-19 antibody ...

SEATTLE, WA, UNITED STATES, February 26, 2026 /EINPresswire.com/ — International Long COVID Awareness Month is observed each year in March to highlight the urgent ...

Invivyd expects to advance VBY329 toward IND readiness in 2H 2026 for development in pediatric RSV prophylaxis, a blockbuster pharmaceutical market in 2024, expected to grow to $3-$4 billion in annual ...

Tiger Tech CEO Harrison Wittels says the company’s wearable biometrics use edge AI to monitor warfighter health in austere ...

Joseph Kosinksi's long-delayed sequel is a confidently rapturous, emotionally involving, take-your-breath-away great time at ...

As a school counselor, David Heavner sees firsthand the mental health issues students deal with, including anxiety and ...

Dr. Omer Awan details lessons from COVID-19 that should be driving the U.S. response in order to contain the Andes hantavirus ...

Advocates, survivors and community leaders are raising thousands of dollars for research, financial assistance and awareness ...

Invivyd authors evaluated early side effects of prior low-dose investigational monoclonal antibody adintrevimab from the EVADE study, ...

The CDC's Epidemic Intelligence Service was on the chopping block last year by the Trump administration. Scientists had a study assessing COVID vaccine effectiveness suppressed by its leadership.